(Q37152738)

18 August 2017

1 reference

title

Molecular genetic characterization reveals new subsets of mantle cell lymphoma (English)

1 reference

18 August 2017

author name string

Emma Flordal Thelander

series ordinal

1

1 reference

18 August 2017

Richard Rosenquist

series ordinal

2

1 reference

18 August 2017

publication date

1 June 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

49

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

1042-1049

1 reference

Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the Eur

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: res

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Current treatment approaches for mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Proteasome inhibition with bortezomib: a new therapeutic strategy for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Location, location, location: the role of cyclin D1 nuclear localization in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

The RAG proteins and V(D)J recombination: complexes, ends, and transposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Somatic hypermutation of immunoglobulin genes: merging mechanisms for genetic diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Cellular origin of human B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter Pylori eradication and detection of API2-MALT1 fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

MALT lymphoma : recent advances in aetiology and molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Hepatitis C virus and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Somatic hypermutation and V(H) gene usage in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Human rheumatoid factors with restrictive specificity for rabbit immunoglobulin G: auto- and multi-reactivity, diverse VH gene segment usage and preferential usage of V lambda IIIb

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Immunoglobulin variable genes and epitope recognition of human monoclonal anti-Ro 52-kd in primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Molecular basis of mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Genomic aberrations and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801947559

10.1080/10428190801947559

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference